These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1724917)

  • 1. Alpha 2-macroglobulin restricts plasminogen activation to the surface of RC2A leukemia cells.
    Stephens RW; Tapiovaara H; Reisberg T; Bizik J; Vaheri A
    Cell Regul; 1991 Dec; 2(12):1057-65. PubMed ID: 1724917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.
    Bizik J; Lizonová A; Stephens RW; Grófová M; Vaheri A
    Cell Regul; 1990 Nov; 1(12):895-905. PubMed ID: 1712633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
    J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
    Pöllänen J; Vaheri A; Tapiovaara H; Riley E; Bertram K; Woodrow G; Stephens RW
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2230-4. PubMed ID: 2138329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of plasmin-mediated pro-urokinase activation on the surface of human monocytoid leukemia cells in vitro.
    Tapiovaara H; Stephens RW; Vaheri A
    Int J Cancer; 1993 Feb; 53(3):499-505. PubMed ID: 8428801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
    Mars WM; Kim TH; Stolz DB; Liu ML; Michalopoulos GK
    Cancer Res; 1996 Jun; 56(12):2837-43. PubMed ID: 8665523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional characterization of the inhibition of urokinase by alpha 2-macroglobulin.
    Straight DL; Hassett MA; McKee PA
    Biochemistry; 1985 Jul; 24(15):3902-7. PubMed ID: 2413880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages.
    Saksela O; Hovi T; Vaheri A
    J Cell Physiol; 1985 Jan; 122(1):125-32. PubMed ID: 2578131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.
    Kirchheimer JC; Wojta J; Christ G; Binder BR
    Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5424-8. PubMed ID: 2501786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.
    Kroon ME; Koolwijk P; van Goor H; Weidle UH; Collen A; van der Pluijm G; van Hinsbergh VW
    Am J Pathol; 1999 Jun; 154(6):1731-42. PubMed ID: 10362798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A T-cell-related proteinase expressed by T-lymphoma cells activates their endogenous pro-urokinase.
    Brunner G; Vettel U; Jobstmann S; Kramer MD; Schirrmacher V
    Blood; 1992 Apr; 79(8):2099-106. PubMed ID: 1562736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
    van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
    Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
    Schuster WA; Medcalf RL; Kruithof EK
    Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
    Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
    Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR; Webb AC; Sitrin RG
    J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
    Waghray A; Webber MM
    Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.